Middletown, DE -- (SBWIRE) -- 09/07/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Acasti Pharma Inc(NASDAQ:ACST), Alaska Communications Systems Group Inc(NASDAQ:ALSK), Delcath Systems, Inc.(NASDAQ:DCTH), Chelsea Therapeutics International Ltd.(NASDAQ:CHTP).
Acasti Pharma Inc(NASDAQ:ACST) ended higher +8.05% and complete the day at $2.55. The total number of shares changed hands during the day was 1.14 million. After opening at $2.49, the stock hit as high as $2.55. However, it traded between $1.61 and $4.20 over the last twelve months.
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders.
For How Long ACST will Fight for Profitability? Read This Trend Analysis report
Alaska Communications Systems Group Inc(NASDAQ:ALSK) closed yesterday at $2.70, a +0.37% increase. Around 1.14 million shares were traded, low from an-average trading volume of 1.51 million shares. The company is now valued at around $125.97 million.
Alaska Communications Systems Group, Inc., through its subsidiaries, provides integrated communications services to business and consumer customers in Alaska and internationally. It provides communications and managed services, including voice and broadband data network hosting, IT management,
For How Long ALSK Gloss will Attract Investors? Find out via this report
Delcath Systems, Inc.(NASDAQ:DCTH) moved +2.78 percent higher at $0.400 and traded between $0.37 and $0.40 after opening the day at $0.40. Its performance over the last five days remained 19.13%, which stands at 2.25% for a month. Going back further than one month, 1-year performance after recent close was -67.5%.
Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology. The company?s proprietary technology enables the administration of high-dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents.
For How Long DCTH Gloss will Attract Investors? Find out via this report
Chelsea Therapeutics International Ltd.(NASDAQ:CHTP) shares rose, gaining +0.95 percent to close at $3.20. The stock is up around 321.05% this year and 204.76% for the last 12 months. Around 1.12 million shares changed hands yesterday, higher from an-average trading volume of 986,820 shares.
Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products. It is primarily developing Northera (droxidopa)
Why Should Investors Buy CHTP After The Recent Gain? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)